Literature DB >> 6861270

Methotrexate metabolism.

G R Krakower, B A Kamen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6861270     DOI： 10.1007/bf00255773

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  5 in total

1.  Separation and identification of subpicomole amounts of methotrexate polyglutamates in animal and human biopsy material.

Authors:  G R Krakower; P A Nylen; B A Kamen
Journal:  Anal Biochem       Date:  1982-05-15       Impact factor: 3.365

2.  The in vivo distribution of methotrexate between plasma and erythrocytes.

Authors:  W H Steele; J F Stuart; J R Lawrence; C A McNeill
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug.

Authors:  B A Kamen; P A Nylen; B M Camitta; J R Bertino
Journal:  Br J Haematol       Date:  1981-11       Impact factor: 6.998

4.  The transport and accumulation of methotrexate in human erythrocytes.

Authors:  M da Costa; M P Iqbal
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

5.  Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate.

Authors:  A Schalhorn; H Sauer; W Wilmanns; G Stupp-Poutot
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
  5 in total
  2 in total

1.  Methotrexate pharmacokinetics in age-fractionated erythrocytes.

Authors:  H Schrøder
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia.

Authors:  H Schrøder; K Fogh
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.